67 related articles for article (PubMed ID: 33282452)
1. Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol.
Zhang L; Wang G; Li Z; Yang J; Li H; Wang W; Li Z; Li H
Phytomedicine; 2024 Jun; 132():155826. PubMed ID: 38897045
[TBL] [Abstract][Full Text] [Related]
2. Ketogenic diet as a potential intervention for lipedema.
Keith L; Seo CA; Rowsemitt C; Pfeffer M; Wahi M; Staggs M; Dudek J; Gower B; Carmody M
Med Hypotheses; 2021 Jan; 146():110435. PubMed ID: 33303304
[TBL] [Abstract][Full Text] [Related]
3. Exploring the highs and lows of very low carbohydrate high fat diets on weight loss and diabetes- and cardiovascular disease-related risk markers: A systematic review.
Ross LJ; Byrnes A; Hay RL; Cawte A; Musial JE
Nutr Diet; 2021 Feb; 78(1):41-56. PubMed ID: 33283417
[TBL] [Abstract][Full Text] [Related]
4. The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab.
Goldschmidt J; Hanes V
Oncol Ther; 2021 Jun; 9(1):213-223. PubMed ID: 33336310
[TBL] [Abstract][Full Text] [Related]
5. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Klein P; Tyrlikova I; Zuccoli G; Tyrlik A; Maroon JC
Cancer Metab; 2020 Nov; 8(1):24. PubMed ID: 33292598
[TBL] [Abstract][Full Text] [Related]
6. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.
Chen TC; da Fonseca CO; Levin D; Schönthal AH
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959448
[TBL] [Abstract][Full Text] [Related]
7. Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.
Chen TC; Fonseca CO; Schönthal AH
Am J Cancer Res; 2015; 5(5):1580-93. PubMed ID: 26175929
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
Da Fonseca CO; Masini M; Futuro D; Caetano R; Gattass CR; Quirico-Santos T
Surg Neurol; 2006 Dec; 66(6):611-5. PubMed ID: 17145324
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy.
Santos JG; Faria G; Cruz WDCSD; Fontes CA; Schönthal AH; Quirico-Santos T; da Fonseca CO
Surg Neurol Int; 2020; 11():389. PubMed ID: 33282452
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
13. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Da Fonseca CO; Silva JT; Lins IR; Simão M; Arnobio A; Futuro D; Quirico-Santos T
Invest New Drugs; 2009 Dec; 27(6):557-64. PubMed ID: 19139816
[TBL] [Abstract][Full Text] [Related]
15. Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: a retrospective study.
Ge JJ; Li C; Qi SP; Xue FJ; Gao ZM; Yu CJ; Zhang JP
BMC Cancer; 2020 Jan; 20(1):24. PubMed ID: 31914946
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
